These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 22617773)
1. Antitumor effects of FP3 in combination with capecitabine on PDTT xenograft models of primary colon carcinoma and related lymphatic and hepatic metastases. Jin K; Lan H; Xie B; He K; Xu Z; Li G; Han N; Teng L; Cao F Cancer Biol Ther; 2012 Jul; 13(9):737-44. PubMed ID: 22617773 [TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of FP3 in combination with cetuximab on patient-derived tumor tissue xenograft models of primary colon carcinoma and related lymphatic and hepatic metastases. Dong X; Jin K; Hu X; Du F; Lan H; Han N; Ma Z; Xie B; Cui B; Teng L; Cao F Int J Mol Med; 2012 Jul; 30(1):126-32. PubMed ID: 22505231 [TBL] [Abstract][Full Text] [Related]
3. Antitumor effect of FP3 on a patient-derived tumor tissue xenograft model of rectal carcinoma. Bi T; Bi T; Lan H; Hu X; Zhu M; Xu Z; Hu J; Teng L; Jin K Hepatogastroenterology; 2013; 60(128):1950-4. PubMed ID: 24719933 [TBL] [Abstract][Full Text] [Related]
4. Heterogeneity-related anticancer therapy response differences in metastatic colon carcinoma: new hints to tumor-site-based personalized cancer therapy. Pan W; Huang S; Zhang J; Zhao B; Wang H; Liu F; Jin K; Mou X Hepatogastroenterology; 2013; 60(128):1927-34. PubMed ID: 24719929 [TBL] [Abstract][Full Text] [Related]
5. Differential response to EGFR- and VEGF-targeted therapies in patient-derived tumor tissue xenograft models of colon carcinoma and related metastases. Jin K; Lan H; Cao F; Han N; Xu Z; Li G; He K; Teng L Int J Oncol; 2012 Aug; 41(2):583-8. PubMed ID: 22581265 [TBL] [Abstract][Full Text] [Related]
6. Assessment of a novel VEGF targeted agent using patient-derived tumor tissue xenograft models of colon carcinoma with lymphatic and hepatic metastases. Jin K; Li G; Cui B; Zhang J; Lan H; Han N; Xie B; Cao F; He K; Wang H; Xu Z; Teng L; Zhu T PLoS One; 2011; 6(12):e28384. PubMed ID: 22164281 [TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of bevacizumab in combination with capecitabine and oxaliplatin in human colorectal cancer xenograft models. Yanagisawa M; Fujimoto-Ouchi K; Yorozu K; Yamashita Y; Mori K Oncol Rep; 2009 Aug; 22(2):241-7. PubMed ID: 19578762 [TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of erlotinib in combination with capecitabine in human tumor xenograft models. Ouchi KF; Yanagisawa M; Sekiguchi F; Tanaka Y Cancer Chemother Pharmacol; 2006 May; 57(5):693-702. PubMed ID: 16362295 [TBL] [Abstract][Full Text] [Related]
9. FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects. Gao W; Jin K; Lan H; Han N; Cao F; Teng L Hepatogastroenterology; 2012; 59(120):2543-7. PubMed ID: 22534543 [TBL] [Abstract][Full Text] [Related]
11. Anti-angiogenesis participates in antitumor effects of metronomic capecitabine on colon cancer. Shi H; Jiang J; Ji J; Shi M; Cai Q; Chen X; Yu Y; Liu B; Zhu Z; Zhang J Cancer Lett; 2014 Jul; 349(2):128-35. PubMed ID: 24746899 [TBL] [Abstract][Full Text] [Related]
12. Lidamycin up-regulates the expression of thymidine phosphorylase and enhances the effects of capecitabine on the growth and pulmonary metastases of murine breast carcinoma. Zhang SH; Zhang H; He HW; Li L; Li XQ; Zhang YP; Shao RG Cancer Chemother Pharmacol; 2013 Oct; 72(4):777-88. PubMed ID: 23975242 [TBL] [Abstract][Full Text] [Related]
13. Bevacizumab-enhanced antitumor effect of 5-fluorouracil via upregulation of thymidine phosphorylase through vascular endothelial growth factor A/vascular endothelial growth factor receptor 2-specificity protein 1 pathway. Liu W; Zhang J; Yao X; Jiang C; Ni P; Cheng L; Liu J; Ni S; Chen Q; Li Q; Zhou K; Wang G; Zhou F Cancer Sci; 2018 Oct; 109(10):3294-3304. PubMed ID: 30151975 [TBL] [Abstract][Full Text] [Related]
14. [ Kim SY; Jung JH; Lee HJ; Soh H; Lee SJ; Oh SJ; Chae SY; Lee JH; Lee SJ; Hong YS; Kim TW; Moon DH Cancer Res; 2017 Dec; 77(24):7120-7130. PubMed ID: 29055019 [TBL] [Abstract][Full Text] [Related]
15. Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts. Sawada N; Ishikawa T; Fukase Y; Nishida M; Yoshikubo T; Ishitsuka H Clin Cancer Res; 1998 Apr; 4(4):1013-9. PubMed ID: 9563897 [TBL] [Abstract][Full Text] [Related]
16. Schedule dependency of antitumor activity in combination therapy with capecitabine/5'-deoxy-5-fluorouridine and docetaxel in breast cancer models. Fujimoto-Ouchi K; Tanaka Y; Tominaga T Clin Cancer Res; 2001 Apr; 7(4):1079-86. PubMed ID: 11309360 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of angiogenesis and intrahepatic growth of colon cancer by TAC-101. Murakami K; Sakukawa R; Sano M; Hashimoto A; Shibata J; Yamada Y; Saiki I Clin Cancer Res; 1999 Sep; 5(9):2304-10. PubMed ID: 10499597 [TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases. Bruns CJ; Liu W; Davis DW; Shaheen RM; McConkey DJ; Wilson MR; Bucana CD; Hicklin DJ; Ellis LM Cancer; 2000 Aug; 89(3):488-99. PubMed ID: 10931447 [TBL] [Abstract][Full Text] [Related]
19. Anti-metastatic effect of capecitabine on human colon cancer xenografts in nude mouse rectum. Ninomiya I; Terada I; Yoshizumi T; Takino T; Nagai N; Morita A; Fushida S; Nishimura G; Fujimura T; Ohta T; Miwa K Int J Cancer; 2004 Oct; 112(1):135-42. PubMed ID: 15305385 [TBL] [Abstract][Full Text] [Related]
20. Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine. Prasad S; Yadav VR; Sung B; Reuter S; Kannappan R; Deorukhkar A; Diagaradjane P; Wei C; Baladandayuthapani V; Krishnan S; Guha S; Aggarwal BB Clin Cancer Res; 2012 Sep; 18(18):4942-53. PubMed ID: 22832932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]